Results for tag: "Gastroesophageal Reflux Disease"

Gastroesophageal Reflux Disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the esophagus and stomach. GERD occurs when the LES relaxes too often or for too long, allowing stomach acid to flow back up into the esophagus. Symptoms of GERD include heartburn, regurgitation, chest pain, and difficulty swallowing. Treatment options for GERD include lifestyle changes, medications, and surgery. The Gastroenterology market is a rapidly growing field, with GERD being one of the most common digestive disorders. GERD is a major cause of morbidity and mortality, and its prevalence is increasing due to lifestyle changes and an aging population. GERD is a major focus of research and development in the Gastroenterology market, with many companies developing new treatments and therapies. Some companies in the Gastroesophageal Reflux Disease market include AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. Show Less Read more